Daniel J. Lippis, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 500 shares at $68.76 ($34K) on 2025-01-16, disclosed to the SEC on 2025-01-16.
Scheduled sale ($34k) by CVP, JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |